OS Therapies Incorporated
OSTX
$1.86
$0.031.64%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.63M | -10.40M | -13.46M | -6.88M | -4.54M |
| Total Depreciation and Amortization | 124.90K | 124.90K | 124.90K | 124.90K | 112.50K |
| Total Amortization of Deferred Charges | 5.10K | 69.00K | 1.04M | -- | -- |
| Total Other Non-Cash Items | 1.37M | 1.72M | 1.60M | 1.05M | 613.10K |
| Change in Net Operating Assets | 1.60M | 3.91M | 6.96M | 994.20K | 1.45M |
| Cash from Operations | -5.53M | -4.56M | -3.73M | -4.71M | -2.36M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | -292.80K |
| Cash from Investing | -- | -- | 0.00 | 0.00 | -292.80K |
| Total Debt Issued | 0.00 | 1.84M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.82M | 3.38M | 1.59M | 6.26M | 2.48M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 600.00 |
| Repurchase of Preferred Stock | -- | -- | -600.00 | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 530.20K | -2.48M | -- |
| Cash from Financing | 4.82M | 5.21M | 2.12M | 3.78M | 2.48M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -712.50K | 647.70K | -1.61M | -925.40K | -169.00K |